Mathieu Glaizal

Dr. Mathieu Glaizal

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2009 in Toxins
Verified
Journal Article
Open access
PDF file
LHLuc De Haro
Luc De Haro
MGMathieu Glaizal
Mathieu Glaizal
LTLucia Tichadou
Lucia Tichadou
IBIngrid Blanc-Brisset
Ingrid Blanc-Brisset
MHMaryvonne Hayek-Lanthois
Maryvonne Hayek-Lanthois
A retrospective case review study of viper envenomations collected by the Marseille’s Poison Centre between 1996 and 2008 was performed. Results: 174 cases were studied (52 grade 1 = G1, 90 G2 and 32 G3). G1 patients received symptomatic treatments (average hospital stay 0.96 day). One hundred and six (106) of the G2/G3 patients were treated with the antivenom Viperfav* (2.1+/-0.9 days in hospital), while 15 of them received symptomatic treatments only (plus one immediate death) (8.1+/-4 days in hospital, 2 of them died). The hospital stay was significantly reduced in the antivenom treated group (p < 0.001), and none of the 106 antivenom treated patients had immediate (anaphylaxis) or delayed (serum sickness) allergic reactions. Conclusion: Viperfav* antivenom was safe and effective for treating asp viper venom-induced toxicity.

10 October 2012 in Clinical Toxicology
Verified
Journal Article
Closed access
MGMathieu Glaizal
Mathieu Glaizal
VGVincent Gazin
Vincent Gazin
IAIsabelle Aymard
Isabelle Aymard
CMCatherine Messina-Gourlot
Catherine Messina-Gourlot
NRNathalie Richard
Nathalie Richard
LHLuc De Haro
Luc De Haro
Context. Methadone is used in France since March 1995, only for opioid maintenance treatment, in a syrup form. For the launching of a capsule form in April 2008, French health authorities requested a prospective survey of all cases involving exposure to methadone in either of the two available pharmaceutical forms. Objective. The aim was to document, in different circumstances and compare the safety of the new capsule form to the syrup. This report presents the findings of one arm of the study, devoted to methadone-related suicide attempts. Materials and method. From April 15, 2008 to April 15, 2010, all self-injurious methadone poisonings notified to or managed by the French Toxicovigilance Centers network were included. Analysis mainly focused on patients’ age and gender, estimated quantity ingested, eventual concomitantly taken substances, distribution of symptoms, and site of treatment. Results. 135 methadone-related suicide attempts were recorded. Analysis showed identical epidemiologic and clinical patient characteristics for the two pharmaceutical forms. Ten deaths occurred. The only discrepancy was a higher incidence of suicide attempts in the capsule group. However, as the number of capsule-treated patients increased during the second year, this difference remained significant but tended to decrease. Discussion. Combining these results with Pharmacovigilance and Addictovigilance arms, health authorities estimated that the benefit/risk balance of this new pharmaceutical form remains positive. They revised their position on requirements for prescribing and dispensing of the capsule form, and made them slightly easier. Following this, this “suicide” arm of Toxicovigilance survey was suspended, whereas the second one, concerning accidental pediatric methadone-related poisonings, has been extended until April 2014. Conclusion. In France, suicide attempts were more likely to occur with the capsule formulation. The clinical severity of intoxication was similar between the capsule and liquid forms.

1 October 2013 in La Presse Médicale
Verified
Journal Article
Closed access
MGMathieu Glaizal
Mathieu Glaizal
CSCorinne Schmitt
Corinne Schmitt
LTLucia Tichadou
Lucia Tichadou
JSJean-Marc Sapori
Jean-Marc Sapori
MHMaryvonne Hayek-Lanthois
Maryvonne Hayek-Lanthois
LHLuc De Haro
Luc De Haro

24 November 2023 in Toxins
Verified
Journal Article
Open access
PDF file
RTromain torrents
romain torrents
JRJulien Reynoard
Julien Reynoard
MGMathieu Glaizal
Mathieu Glaizal
CSCorinne Schmitt
Corinne Schmitt
KFKatharina von Fabeck
Katharina von Fabeck
Nicolas SimonNicolas Simon
Nicolas Simon
Introduction: In a few regions of the globe, deliberate botanical intoxication may induce significant rates of toxicity and fatality. The objective of this report was to describe plant self-intoxication using the experiences of the southeastern France poison control center (PCC) between 2002 and 2021. Results: During those 20 years, 262 deliberate plants poisonings were reported involving 35 various plants. In most of the cases, poisoning was caused by Nerium oleander (n = 186, 71%), followed by the Datura genus (4.2%), Ricinus communis (3.8%), Taxus baccata (1.9%), Digitalis purpurea (1.2%), Aconitum nape (1.9%), Myristica fragans (1.5%), and Pyracantha coccine (1.2%). Through the 262 plants poisonings, 19 patients among the 186 Nerium oleander poisonings received Digifab as an antidote and 1 patient received physostigmine among the 11 Datura poisonings. Only four deaths were reported for this review, each involving Nerium oleander. Discussion: The first involved species was Nerium oleander (71% of all plants poisonings), then Datura sp and Ricinus communis. It is explained by this native local species’ important repartition. Most patients must be admitted to an emergency department for adapted medical care; however, only 41 of them described severe poisonings symptoms. Even fewer needed an antidote, only 20 patients. There is no protocol for the use of a specific treatment, and it might be interesting to develop one for this purpose. Material and Methods: This retrospective review was realized with files managed by the southeastern France PCC based in Marseille from 2002 to 2021. Our department covers the complete French Mediterranean coast, Corsica, and tropical islands (Reunion Island, Mayotte). For every patient, toxicity was evaluated using the Poison Severity Score (PSS).

1 January 2017 in La Presse Médicale
Verified
Journal Article
Closed access
RTromain torrents
romain torrents
MGMathieu Glaizal
Mathieu Glaizal
CSCorinne Schmitt
Corinne Schmitt
ABAudrey Boulamery
Audrey Boulamery
LHLuc De Haro
Luc De Haro
Nicolas SimonNicolas Simon
Nicolas Simon

1 June 2012 in La Presse Médicale
Verified
Journal Article
Closed access
MGMathieu Glaizal
Mathieu Glaizal
VAVéronique Alunni
Véronique Alunni
JAJean-Jacques Arzalier
Jean-Jacques Arzalier
GPGérard Page
Gérard Page
YGYvan Gaillard
Yvan Gaillard
LHLuc De Haro
Luc De Haro